[go: up one dir, main page]

PE20130179A1 - Nuevos derivados terciarios de 8-hidroxiquinolina-7-carboxamida - Google Patents

Nuevos derivados terciarios de 8-hidroxiquinolina-7-carboxamida

Info

Publication number
PE20130179A1
PE20130179A1 PE2012000845A PE2012000845A PE20130179A1 PE 20130179 A1 PE20130179 A1 PE 20130179A1 PE 2012000845 A PE2012000845 A PE 2012000845A PE 2012000845 A PE2012000845 A PE 2012000845A PE 20130179 A1 PE20130179 A1 PE 20130179A1
Authority
PE
Peru
Prior art keywords
carboxamide
hydroxy
hydroxyquinoline
methyl
compound
Prior art date
Application number
PE2012000845A
Other languages
English (en)
Inventor
Stefania Gagliardi
Sordo Simone Del
Federico Mailland
Michela Legora
Original Assignee
Polichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42026678&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20130179(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Polichem Sa filed Critical Polichem Sa
Publication of PE20130179A1 publication Critical patent/PE20130179A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/113Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA (I) DONDE: R2 Y R3 SON INDEPENDIENTEMENTE ALQUILO C1-C6 CON LA CONDICION QUE AMBOS NO SEAN METILO, (CH2)n-CICLOALQUILO, (CH2)n-HETEROCICLO, (CH2)n-CN, ENTRE OTROS, O JUNTOS CON EL NITROGENO AL CUAL ESTAN UNIDOS FORMAN UN HETEROMONOCICLO DE 5 A 8 MIEMBROS QUE CONTIENE DE UNO A TRES HETEROATOMOS TALES COMO O Y S, O JUNTOS CON EL ATOMO DE NITROGENO AL CUAL ESTAN UNIDOS FORMAN DIHIDROQUINOLINA SUSTITUIDA POR HALOGENO Y/O HIDROXI; n ES UN ENTERO DE 0 A 2. SON COMPUESTOS PREFERIDOS: 8-HIDROXI-N-METIL-N-FENETILQUINOLINA-7-CARBOXAMIDA; N-(FURAN-2-ILMETIL)-8-HIDROXI-N-METILQUINOLINA-7-CARBOXAMIDA; ENTRE OTROS. REFERIDO ADEMAS A UNA FORMULACION FARMACEUTICA. DICHO COMPUESTO ES UTIL PARA EL TRATAMIENTO Y/O PREVENCION DE INFECCIONES FUNGICAS
PE2012000845A 2009-12-29 2010-12-28 Nuevos derivados terciarios de 8-hidroxiquinolina-7-carboxamida PE20130179A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09180902A EP2345643A1 (en) 2009-12-29 2009-12-29 New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof

Publications (1)

Publication Number Publication Date
PE20130179A1 true PE20130179A1 (es) 2013-02-24

Family

ID=42026678

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2012000845A PE20130179A1 (es) 2009-12-29 2010-12-28 Nuevos derivados terciarios de 8-hidroxiquinolina-7-carboxamida

Country Status (38)

Country Link
US (1) US8729098B2 (es)
EP (2) EP2345643A1 (es)
JP (1) JP5808754B2 (es)
KR (1) KR101666505B1 (es)
CN (2) CN102686566A (es)
AU (1) AU2010338267B2 (es)
BR (1) BR112012015728A2 (es)
CA (1) CA2783213C (es)
CL (1) CL2012001757A1 (es)
CY (1) CY1116493T1 (es)
DK (1) DK2519505T3 (es)
DO (1) DOP2012000186A (es)
EA (1) EA025563B1 (es)
EC (1) ECSP12012007A (es)
ES (1) ES2540327T3 (es)
GE (1) GEP20156244B (es)
GT (1) GT201200216A (es)
HK (1) HK1178526A1 (es)
HR (1) HRP20150749T1 (es)
HU (1) HUE027220T2 (es)
IL (1) IL220427A (es)
MA (1) MA33829B1 (es)
MX (1) MX2012007748A (es)
MY (1) MY161869A (es)
NI (1) NI201200114A (es)
NZ (1) NZ600788A (es)
PE (1) PE20130179A1 (es)
PH (1) PH12012501326A1 (es)
PL (1) PL2519505T3 (es)
PT (1) PT2519505E (es)
RS (1) RS54096B1 (es)
SG (1) SG181586A1 (es)
SI (1) SI2519505T1 (es)
SM (1) SMT201500182B (es)
TN (1) TN2012000320A1 (es)
UA (1) UA107949C2 (es)
WO (1) WO2011080264A1 (es)
ZA (1) ZA201204347B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2345641A1 (en) * 2009-12-29 2011-07-20 Polichem S.A. New secondary 8-hydroxyquinoline-7-carboxamide derivatives
EP2345642A1 (en) * 2009-12-29 2011-07-20 Polichem S.A. Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents
CA2857262A1 (en) * 2012-02-24 2013-08-29 F. Hoffmann-La Roche Ag Antiviral compounds
US9751838B2 (en) 2012-10-02 2017-09-05 Institut National De La Sante Et De La Recherche Medicale (Inserm) Tetrahydroquinoline derivatives and their use as Epac inhibitors
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
EP4217614A4 (en) 2020-09-22 2024-12-18 Milwaukee Electric Tool Corporation BRACKET AND BRACKET ASSEMBLY
USD976093S1 (en) 2020-09-22 2023-01-24 Milwaukee Electric Tool Corporation Staple collation
EP4237201A4 (en) 2020-10-30 2024-12-11 Milwaukee Electric Tool Corporation POWERED FASTENER DRIVER

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US326330A (en) 1885-09-15 Harness-support
US326328A (en) 1885-09-15 Broiler
DE540842C (de) 1930-08-06 1931-12-28 Chinosol Fabrik Akt Ges Verfahren zur Darstellung der 8-Acetyloxychinolin-7-carbonsaeure
CN1180995A (zh) 1995-04-08 1998-05-06 巴斯福股份公司 防治有害真菌的方法
WO1997017973A1 (en) * 1995-11-13 1997-05-22 Smithkline Beecham Corporation Hemoregulatory compounds
WO1998011073A1 (en) 1996-09-10 1998-03-19 Pharmacia & Upjohn Company 8-hydroxy-7-substituted quinolines as anti-viral agents
KR20010015639A (ko) * 1997-09-30 2001-02-26 스즈키 다다시 술포닐 유도체
JP2001294572A (ja) * 2000-02-09 2001-10-23 Dai Ichi Seiyaku Co Ltd 新規スルホニル誘導体
AU1532802A (en) 2000-10-12 2002-04-22 Merck & Co Inc Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors
YU27903A (sh) 2000-10-12 2006-05-25 Merck & Co. Inc. Aza- i poliaza-naftalenil karboksamidi korisni kao inhibitori hiv-integraze
US7148237B2 (en) 2001-03-01 2006-12-12 Shionogi & Co., Ltd. Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity
WO2004024693A1 (ja) 2002-08-13 2004-03-25 Shionogi & Co., Ltd. Hivインテグラーゼ阻害活性を有するヘテロ環化合物
US7932272B2 (en) * 2003-09-30 2011-04-26 Eisai R&D Management Co., Ltd. Antifungal agent containing heterocyclic compound
FR2889192A1 (fr) * 2005-07-27 2007-02-02 Cytomics Systems Sa Composes antifongiques, compositions contenant ces composes et leurs utilisations
CN101495186A (zh) * 2006-07-26 2009-07-29 诺瓦提斯公司 十一异戊二烯基焦磷酸酯合酶的抑制剂
WO2009140215A2 (en) * 2008-05-11 2009-11-19 Geraghty, Erin Method for treating drug-resistant bacterial and other infections with clioquinol, phanquinone, and related compounds
KR101550557B1 (ko) * 2009-11-10 2015-09-04 화이자 인코포레이티드 N1-피라졸로스피로케톤 아세틸-coa 카복실라아제 억제제
TW201130842A (en) * 2009-12-18 2011-09-16 Incyte Corp Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors
EP2345641A1 (en) * 2009-12-29 2011-07-20 Polichem S.A. New secondary 8-hydroxyquinoline-7-carboxamide derivatives
EP2345642A1 (en) * 2009-12-29 2011-07-20 Polichem S.A. Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents

Also Published As

Publication number Publication date
CN102686566A (zh) 2012-09-19
WO2011080264A1 (en) 2011-07-07
MA33829B1 (fr) 2012-12-03
IL220427A (en) 2015-04-30
US8729098B2 (en) 2014-05-20
DK2519505T3 (en) 2015-06-29
PH12012501326A1 (en) 2015-04-01
ECSP12012007A (es) 2012-08-31
AU2010338267B2 (en) 2014-03-27
TN2012000320A1 (en) 2013-12-12
EA025563B1 (ru) 2017-01-30
RS54096B1 (en) 2015-10-30
MY161869A (en) 2017-05-15
BR112012015728A2 (pt) 2019-09-24
SG181586A1 (en) 2012-07-30
EA201270670A1 (ru) 2013-03-29
GEP20156244B (en) 2015-02-10
NZ600788A (en) 2013-08-30
DOP2012000186A (es) 2013-01-15
PT2519505E (pt) 2015-09-03
GT201200216A (es) 2014-12-26
CY1116493T1 (el) 2017-03-15
CL2012001757A1 (es) 2013-03-22
AU2010338267A1 (en) 2012-07-19
AU2010338267A2 (en) 2012-07-26
EP2345643A1 (en) 2011-07-20
KR20120101563A (ko) 2012-09-13
SI2519505T1 (sl) 2015-08-31
CA2783213A1 (en) 2011-07-07
JP5808754B2 (ja) 2015-11-10
NI201200114A (es) 2013-04-22
EP2519505A1 (en) 2012-11-07
SMT201500182B (it) 2015-09-07
US20120309751A1 (en) 2012-12-06
PL2519505T3 (pl) 2015-11-30
UA107949C2 (xx) 2015-03-10
MX2012007748A (es) 2012-08-03
ES2540327T3 (es) 2015-07-09
HK1178526A1 (en) 2013-09-13
HUE027220T2 (hu) 2016-10-28
JP2013515755A (ja) 2013-05-09
CA2783213C (en) 2017-09-12
ZA201204347B (en) 2013-09-25
CN105384685A (zh) 2016-03-09
EP2519505B1 (en) 2015-05-27
KR101666505B1 (ko) 2016-10-14
HRP20150749T1 (hr) 2015-08-14

Similar Documents

Publication Publication Date Title
PE20130179A1 (es) Nuevos derivados terciarios de 8-hidroxiquinolina-7-carboxamida
PE20160608A1 (es) Compuestos de quinolina selectivamente sustituida
BRPI1011657A2 (pt) derivados aminopropiônicos substituídos como inibidores de neprilisina
MX2019004679A (es) Oxisteroles y metodos de uso de los mismos.
CR20120190A (es) INHIBIDORES DE N1-PIRAZOLOESPIROCETONA ACETIL-CoA CARBOXILASA
PE20142081A1 (es) Inhibidores de quinurenina-3-monooxigenasa, composiciones farmaceuticas y metodo de uso de los mismos
IN2015DN00185A (es)
EA201101026A1 (ru) Ингибиторы бета-секретазы
MX338707B (es) Compuestos heterociclicos activadores de proteina cinasa activada por 5'-amp (ampk) y metodos para emplearlos.
BR112013011580A2 (pt) derivados de ácido bisfenil pentanoico substituído por amino como inibidores de nep
PH12019501198A1 (en) Tetracyclic heterocycle compounds useful as hiv integrase inhibitors
EA201270216A1 (ru) Фармацевтический состав
MX2016000675A (es) Derivados de amino-metil-biarilo como inhibidores del factor de complemento d y usos de los mismos.
MX2011010415A (es) Formulaciones farmaceuticas que comprenden derivados de nitrocatecol y metodos para hacer las mismas.
PE20142376A1 (es) Fluormetil-5,6-dihidro-4h-[1,3]oxazinas
EA201190320A1 (ru) Гетероциклические сульфонамиды, их применения и фармацевтические композиции
EA201101621A1 (ru) Производные бензоксазолона в качестве ингибиторов альдостеронсинтазы
PH12015501752A1 (en) Substituted bisphenyl butanoic phosphonic acid derivatives as nep inhibitors
BR112012031340A2 (pt) derivados de cianoquinolina
WO2014121055A3 (en) Flap modulators
MX2013011926A (es) Derivados de glicosido y usos de los mismos.
BR112012009311A2 (pt) composto, composição farmacêutica, e, uso do composto
BR112017026904A2 (pt) formulações farmacêuticas injetáveis de lefamulina
PH12014501181A1 (en) N- (4 -quinolinylmethyl) sulfonamide derivatives and their use as anthelmintics
BR112012009861A2 (pt) composto, composição farmacêutica, e, uso do composto.

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed